Session information

Oral Presentation

(E) Pharmaceutical Health Care and Sciences

[27I-pm] Genetic drug delivery system-2

Sun. Mar 27, 2022 4:54 PM - 5:42 PM [Room I] Conference Room 222 (Bldg. 2: 2F)

Chair: Shintaro Fumoto

+Add all to schedule

4:54 PM - 5:06 PM

[27I-pm17S] Regulating the function of erythropoietin-producing cells for the effective and safe treatment of renal anemia

○Kodai Takamura¹, Kosuke Kusamori¹, Mari Tsujimura¹, Makiya Nishikawa¹ (1. Fac. Pharm. Sci., Tokyo Univ. Sci.)

5:06 PM - 5:18 PM

[27I-pm18S] Development of Adenovirus Vectors possessing the Adenovirus Death Protein Gene

○Aoi Shiota¹, Fumitaka Nishimae¹, Fuminori Sakurai¹, Hiroyuki Mizuguchi^1,2,3,4 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. NIBIOHN, 3. MEI cent., Osaka Univ., 4. OTRI, Osaka Univ.)

5:18 PM - 5:30 PM

[27I-pm19S] Development of a novel adenovirus serotype 35 vector vaccine showing high titer production

○Rika Onishi¹, Sena Ikemoto¹, Aoi Shiota¹, Tomohito Tsukamoto¹, Akira Asayama¹, Fuminori Sakurai¹, Hiroyuki Mizuguchi^1,2,3,4 (1. Grad. Sch. of Pharm. Sci., Osaka Univ., 2. NIBIOHN, 3. MEI cent., Osaka Univ.,, 4. OTRI, Osaka Univ)

5:30 PM - 5:42 PM

[27I-pm20] Adeno-associated virus(AAV)-loaded ternary complexes that evade AAV neutralizing antibodies and enhance its activity.

○Yuto Honda^1,2, Shuhei Nagao^1,2, Kinoh Hiroaki³, Takahiro Nomoto^1,2, Xueying Liu³, Anjaneyulu Dirisala ³, Makoto Matsui^1,2, Yutaka Miura^1,2, Nobuhiro Nishiyama^1,2 (1. Lab. for Chem. and Life Sci., Tokyo Tech., 2. Dept. of Life Sci. and Tech., Tokyo Tech., 3. Innovation Center of NanoMedicine.)

Authentication

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Please log in with your participant account.
» Participant Log In

▲